UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses

BMC medical genomics, 2008-05, Vol.1 (1), p.18-18

2008

Link zum Volltext

Verfügbarkeit prüfen

Protective Immune Responses to a Recombinant Adenovirus Type 35 Tuberculosis Vaccine in Two Mouse Strains: CD4 and CD8 T-Cell Epitope Mapping and Role of Gamma Interferon

Infection and Immunity, 2007-08, Vol.75 (8), p.4105-4115

2007

Link zum Volltext

Verfügbarkeit prüfen

Genetic immunization in the lung induces potent local and systemic immune responses

Proceedings of the National Academy of Sciences - PNAS, 2010-12, Vol.107 (51), p.22213-22218

2010

Link zum Volltext

Verfügbarkeit prüfen

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime–boost regimen

Vaccine, 2010-01, Vol.28 (4), p.1084-1093

2010

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

Journal of Virology, 2010-04, Vol.84 (7), p.3699-3706

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Journal of Virology, 2010-08, Vol.84 (15), p.7815-7821

2010

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Nature (London), 2012-02, Vol.482 (7383), p.89-93

2012

Link zum Volltext

Verfügbarkeit prüfen

Advances in tuberculosis vaccine strategies

Nature reviews. Microbiology, 2006-06, Vol.4 (6), p.469-476

2006

Link zum Volltext

Verfügbarkeit prüfen

Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques

Journal of Virology, 2010-06, Vol.84 (12), p.5898-5908

2010

Link zum Volltext

Verfügbarkeit prüfen

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

American journal of respiratory and critical care medicine, 2013-08, Vol.188 (4), p.492-502

2013

Link zum Volltext

Verfügbarkeit prüfen

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge

The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1799-1811

2014

Link zum Volltext

Verfügbarkeit prüfen

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults

American journal of respiratory and critical care medicine, 2010-06, Vol.181 (12), p.1407-1417

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (9), p.1171-1180

2017

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis vaccine research: the impact of immunology

Current opinion in immunology, 2009-06, Vol.21 (3), p.331-338

2009

Link zum Volltext

Verfügbarkeit prüfen

The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses

Vaccine, 2014-10, Vol.32 (45), p.5908-5917

2014

Link zum Volltext

Verfügbarkeit prüfen

Optimizing HIV‐1‐specific CD8+ T‐cell induction by recombinant BCG in prime‐boost regimens with heterologous viral vectors

European journal of immunology, 2011-12, Vol.41 (12), p.3542-3552

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

The New England journal of medicine, 1996-06, Vol.334 (26), p.1697-1702

1996

Link zum Volltext

Verfügbarkeit prüfen

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs

Human vaccines & immunotherapeutics, 2014-08, Vol.10 (8), p.2199-2210

2014

Link zum Volltext

Verfügbarkeit prüfen

Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

Science (American Association for the Advancement of Science), 1995-10, Vol.270 (5234), p.299-302

1995

Link zum Volltext

Verfügbarkeit prüfen

Vaccine risk and benefit in the developing world

Health affairs (Millwood, Va.), 2005-09, Vol.24 (5), p.1379

Sadoff, Jerald C

2005

Link zum Volltext

Verfügbarkeit prüfen

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

The Lancet (British edition), 1997-01, Vol.349 (9046), p.155-159

1997

Link zum Volltext

Verfügbarkeit prüfen

Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection

The Pediatric infectious disease journal, 2002-04, Vol.21 (4), p.337-342

2002

Link zum Volltext

Verfügbarkeit prüfen

DNA vaccines

Current opinion in immunology, 1996-08, Vol.8 (4), p.531-536

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

The New England journal of medicine, 1991-02, Vol.324 (7), p.429-436

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(98)

Sprache

Englisch
(98)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(63)
Biological And Medical Sciences
(48)
Humans
(48)
Animals
(38)
Female
(33)
Immunology
(33)
Fundamental And Applied Biological Sciences. Psychology
(30)
Microbiology
(30)
Infectious Diseases
(28)
Male
(28)
Medical Sciences
(24)
Adult
(20)
Vaccines
(20)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(20)
Mice
(16)
General & Internal Medicine
(15)
Immunization
(14)
Vaccines, Synthetic - Immunology
(14)
Bacteriology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses

Protective Immune Responses to a Recombinant Adenovirus Type 35 Tuberculosis Vaccine in Two Mouse Strains: CD4 and CD8 T-Cell Epitope Mapping and Role of Gamma Interferon

Genetic immunization in the lung induces potent local and systemic immune responses

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime–boost regimen

Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Advances in tuberculosis vaccine strategies

Novel Recombinant Mycobacterium bovis BCG, Ovine Atadenovirus, and Modified Vaccinia Virus Ankara Vaccines Combine To Induce Robust Human Immunodeficiency Virus-Specific CD4 and CD8 T-Cell Responses in Rhesus Macaques

Induction and Regulation of T-Cell Immunity by the Novel Tuberculosis Vaccine M72/AS01 in South African Adults

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial

Tuberculosis vaccine research: the impact of immunology

The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses

Optimizing HIV‐1‐specific CD8+ T‐cell induction by recombinant BCG in prime‐boost regimens with heterologous viral vectors

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs

Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

Vaccine risk and benefit in the developing world

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection

DNA vaccines

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial

Aktive Filter

Suchergebnisse filtern